Crocker Ventures

Crocker Ventures is a venture capital investment firm established in 1998 and located in Salt Lake City, Utah. The firm focuses on investing in startups within the life sciences, healthcare, biotechnology, pharmaceuticals, medical devices, drug delivery, diagnostics, and information technology sectors. In addition to managing its portfolio of startup companies, Crocker Ventures is actively involved in managing intellectual property and exploring opportunities for the acquisition of new technologies. The firm aims to support innovation and growth within its targeted industries through strategic investments and management.

Chad Poulter

Vice President

7 past transactions

Rebel Medicine

Series A in 2025
Rebel Medicine is a preclinical-stage life sciences company focused on developing innovative solutions for opioid-free pain management. The company specializes in injectable, long-acting local anesthetics designed to provide 96 to 120 hours of effective analgesia following surgery, significantly reducing the reliance on opioids. Additionally, Rebel Medicine is working on anesthetic wound dressings for treating painful dermal injuries. Their approach leverages advanced drug delivery science, including a shear-thinning gel formulation that can accommodate a wide range of active pharmaceutical ingredients, including small molecules and peptides. This enables pharmaceutical partners to enhance the effectiveness of existing therapies, ultimately aiming to deliver superior pain management solutions at a lower cost.

IsoTalent

Seed Round in 2022
IsoTalent is a full-service recruiting agency based in Lehi, Utah, specializing in providing global on-demand hiring solutions. The company leverages a team of professional recruiters to deliver personalized recruitment services while utilizing technology-driven applicant tracking and screening methods. By offering affordable hourly rates and high-touch collaboration, IsoTalent aims to provide clients with effective and cost-efficient hiring solutions. Their services are designed to help businesses manage human capital, scale operations internationally, and improve team retention.

TellBio

Venture Round in 2021
TellBio is a biotechnology company focused on cancer treatment. The company specializes in the detection, monitoring, management, and treatment of cancer using its proprietary technology related to circulating tumor cells (CTCs). This innovative approach allows healthcare professionals to effectively detect and monitor the progression of cancer by analyzing tumor cells, ultimately enhancing patient care and treatment outcomes.

Kyte Learning Solutions

Series A in 2014
Kyte Learning provides a personalized learning environment built on an ever-growing video library of highly relevant ed-tech training materials. Expert teachers across the nation create experience-based training courses that teach both technical skills and classroom application strategies. Administrators have the ability to assign, track, and evaluate data to understand what their teachers are training on and help them obtain the tech skills needed to meet school objectives.

iSchool Campus

Venture Round in 2012
iSchool Campus is a provider of innovative educational solutions based in Utah and Washington D.C. The company focuses on creating collaborative learning environments that prioritize individual student needs while supporting educators. Through its digital learning platform, iSchool Campus offers full-time access to technology and educational resources, including training and certification programs for teachers and school staff. The platform also features security measures and filtering systems to ensure a safe online learning experience. By integrating advanced technology with effective teaching practices, iSchool Campus aims to foster creativity and innovation in classrooms, empowering both students and educators in their learning journeys.

Merrimack

Private Equity Round in 2011
Merrimack Pharmaceuticals is a biopharmaceutical company based in Cambridge, Massachusetts, founded in 1993. The company focuses on discovering, designing, and developing innovative therapies for the treatment of cancer and autoimmune diseases. Merrimack employs a systems biology approach, utilizing multidisciplinary capabilities to create functional and predictive computational models of biological systems, particularly cell signaling networks. In addition to its internal development efforts, the company collaborates with third parties to further process and commercialize its products, enhancing its ability to bring novel therapeutics and diagnostics to market.

TMJ Medical

Acquisition in 2010
TMJ Implants (Golden, CO USA), is the recognized world leader in the design and manufacture of alloplastic implants for the treatment of temporomandibular joint disorders and injuries. The company designs and manufactures both stock and custom devices for partial and total joint replacement.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.